This past week, Paul Slocum celebrated 20 years of And/Or gallery, a pioneering space for the exhibition of new media art.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Health Canada has approved KEYTRUDA SC™ (pembrolizumab injection), a new subcutaneous formulation of ...